Clopiwin Plus 75 mg FC tablets.
PDF Leaflet Revision Date: 13 April 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Reduction of atherothrombotic events in adults with acute coronary syndrome.
Dosage (summary)
One tablet daily; no loading dose for patients >75 years.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding.
Key Drug Interactions
- Warfarin
- NSAIDs
- SSRIs
- CYP2C19 inhibitors
Contraindications
- Hypersensitivity
- Active bleeding
- Severe hepatic impairment
- Thrombocytopenia
Common side effects
- Bleeding
- Dyspepsia
- Abdominal pain
- Bruising
Counselling Points
- Report unusual bleeding
- Avoid alcohol
- Inform healthcare providers before surgery
Serious warnings
- Thrombotic Thrombocytopenic Purpura (TTP)
- Increased bleeding risk
On This Page
Loading package insert…
Medinsert AI
Hello! I am Medinsert Ai. What would you like to know about this professional information leaftleft?
